$379 Million is the total value of ADAMS STREET PARTNERS LLC's 14 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCTY | Sell | Paylocity Holding Corporation | $139,338,000 | -16.1% | 863,200 | -24.2% | 36.73% | +6.9% |
| RMNI | Rimini Street, Inc. | $76,296,000 | -37.5% | 23,694,465 | 0.0% | 20.11% | -20.3% | |
| QTWO | Sell | Q2 Holdings, Inc. | $70,960,000 | -23.2% | 777,562 | -27.8% | 18.70% | -2.2% |
| FUSN | Fusion Pharmaceuticals, Inc. | $39,994,000 | -27.4% | 3,502,425 | 0.0% | 10.54% | -7.4% | |
| APTX | Buy | Aptinyx, Inc. | $17,934,000 | -17.6% | 5,305,872 | +1.7% | 4.73% | +5.1% |
| CRVS | Corvus Pharmaceuticals, Inc. | $13,135,000 | +47.4% | 3,275,616 | 0.0% | 3.46% | +87.8% | |
| HCAT | New | Health Catalyst, Inc. | $6,639,000 | – | 201,548 | +100.0% | 1.75% | – |
| GOTU | New | GSX Techedu, Inc.ads | $4,607,000 | – | 51,131 | +100.0% | 1.21% | – |
| TDOC | New | Teladoc Health, Inc. | $4,467,000 | – | 20,377 | +100.0% | 1.18% | – |
| CRSP | New | Crispr Therapeutics AG | $1,854,000 | – | 22,163 | +100.0% | 0.49% | – |
| PD | New | PagerDuty, Inc. | $1,564,000 | – | 57,689 | +100.0% | 0.41% | – |
| New | Progyny, Inc. | $1,332,000 | – | 45,263 | +100.0% | 0.35% | – | |
| ISEE | Sell | IVERIC Bio, Inc. | $870,000 | -44.7% | 154,271 | -50.0% | 0.23% | -29.8% |
| FUTU | New | Futu Holdings Limitedclass a | $401,000 | – | 14,015 | +100.0% | 0.11% | – |
| EPZM | Exit | Epizyme, Inc. | $0 | – | -56,780 | -100.0% | -0.19% | – |
| ZUO | Exit | Zuora, Inc. | $0 | – | -72,714 | -100.0% | -0.19% | – |
| DOCU | Exit | Docusign, Inc. | $0 | – | -29,458 | -100.0% | -1.05% | – |
| WORK | Exit | Slack Technologies, Inc. | $0 | – | -282,005 | -100.0% | -1.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Paylocity Holding Corporation | 35 | Q3 2023 | 52.0% |
| Q2 Holdings, Inc. (fka CBG Holdings, Inc.) | 35 | Q3 2023 | 36.6% |
| Corvus Pharmaceuticals, Inc. | 31 | Q3 2023 | 13.7% |
| Rimini Street, Inc. | 24 | Q3 2023 | 36.9% |
| Aptinyx, Inc. | 20 | Q1 2023 | 17.5% |
| magicJack VocalTec Ltd.(fka VocalTec Communications Ltd./Ymax Corporation) | 18 | Q4 2018 | 71.4% |
| Fusion Pharmaceuticals, Inc. | 14 | Q3 2023 | 11.4% |
| OncoMed Pharmaceuticals, Inc. | 12 | Q4 2017 | 7.5% |
| Icosavax, Inc. | 9 | Q3 2023 | 11.6% |
| Vacasa, Inc. | 8 | Q3 2023 | 24.0% |
View ADAMS STREET PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aptinyx Inc. | June 27, 2023 | 5,395,996 | 8.0% |
| Fusion Pharmaceuticals Inc. | February 14, 2022 | 2,947,809 | 6.8% |
| Rimini Street, Inc. | February 14, 2022 | 23,659,431 | 27.2% |
| Paylocity Holding Corp | February 14, 2020 | 1,738,428 | 3.2% |
| Aptinyx Inc. | February 13, 2019 | 4,030,628 | 12.0% |
| Q2 Holdings, Inc. | February 13, 2019 | 1,643,275 | 3.8% |
| Corvus Pharmaceuticals, Inc. | March 21, 2018 | 3,275,616 | 15.5% |
| MAGICJACK VOCALTEC LTD | February 12, 2018 | 1,976,861 | 12.3% |
| RIMINI STREET, INC. | October 20, 2017 | 22,783,556 | 38.9% |
| Five9, Inc. | February 13, 2017 | 1,766,470 | 3.0% |
View ADAMS STREET PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2023-11-24 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-06-27 |
| SC 13D/A | 2023-06-13 |
| 4 | 2023-06-08 |
| 13F-HR | 2023-05-15 |
View ADAMS STREET PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.